mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
-0.34 |
0.02 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |